Author Yao, Sha

1 to 12 of 12 Items
  • 2017 Conference Paper
    ​ ​Proteomic differentiation of pulmonary cancer with squamous cell histology​
    Bohnenberger, H.; Yepes, D.; Merkelbach-Bruse, S.; Emmert, A.; Lois, A.-M.; Yao, S. & Sitte, M. et al.​ (2017)
    ​Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC pp. 4640​-4640. ​Annual Meeting of the American Association for Cancer Research 2017​, Washington, DC. DOI: https://doi.org/10.1158/1538-7445.AM2017-4640 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis​
    Bohnenberger, H.; Kaderali, L.; Ströbel, P.; Yepes, D.; Plessmann, U.; Dharia, N. V & Yao, S. et al.​ (2018) 
    EMBO Molecular Medicine10(9).​ DOI: https://doi.org/10.15252/emmm.201708428 
    Details  DOI  PMID  PMC 
  • 2019 Journal Article | 
    ​ ​Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer​
    Buentzel, J. ; Yao, S.; Elakad, O.; Lois, A.-M.; Brünies, J.; König, J. & Hinterthaner, M.  et al.​ (2019) 
    Medicine98(31) art. e16712​.​ DOI: https://doi.org/10.1097/MD.0000000000016712 
    Details  DOI  PMID  PMC 
  • 2020 Journal Article | 
    ​ ​Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer​
    Elakad, O.; Lois, A.; Schmitz, K.; Yao, S.; Hugo, S.; Lukat, L. & Hinterthaner, M.  et al.​ (2020) 
    Cancer Medicine9(10) pp. 3574​-3583​.​ DOI: https://doi.org/10.1002/cam4.2994 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​UDP-glucose 6-dehydrogenase expression as a predictor of survival in patients with pulmonary adenocarcinoma​
    Saha, S.; Yao, S.; Elakad, O.; Lois, A.-M.; Henric-Petri, H.; Buentzel, J. & Hinterthaner, M. et al.​ (2020) 
    International Journal of Surgery. Oncology5(2) art. e85​.​ DOI: https://doi.org/10.1097/IJ9.0000000000000085 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Role of Annexin A1 in Squamous Cell Lung Cancer Progression​
    Elakad, O.; Li, Y.; Gieser, N.; Yao, S.; Küffer, S. ; Hinterthaner, M.   & Danner, B. C.  et al.​ (2021) 
    Disease Markers2021 pp. 1​-10​.​ DOI: https://doi.org/10.1155/2021/5520832 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​One carbon metabolism in human lung cancer​
    Yao, S.; Peng, L.; Elakad, O.; Küffer, S. ; Hinterthaner, M. ; Danner, B. C.   & Hammerstein-Equord, A. von et al.​ (2021) 
    Translational Lung Cancer Research10(6) pp. 2523​-2538​.​ DOI: https://doi.org/10.21037/tlcr-20-1039 
    Details  DOI 
  • 2022 Journal Article | 
    ​ ​Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer​
    Elakad, O.; Häupl, B.; Labitzky, V.; Yao, S.; Küffer, S. ; von Hammerstein-Equord, A. & Danner, B.  et al.​ (2022) 
    npj Precision Oncology6(1).​ DOI: https://doi.org/10.1038/s41698-022-00296-2 
    Details  DOI 
  • 2022 Journal Article | Research Paper | 
    ​ ​Expression and prognostic impact of CD49b in human lung cancer​
    Tirilomi, A.; Elakad, O.; Yao, S.; Li, Y.; Hinterthaner, M. ; Danner, B. C.   & Ströbel, P.  et al.​ (2022) 
    Medicine101(6) art. e28814​.​ DOI: https://doi.org/10.1097/MD.0000000000028814 
    Details  DOI  PMID  PMC 
  • 2022 Journal Article | Research Paper | 
    ​ ​Regulation and Therapeutic Targeting of MTHFD2 and EZH2 in KRAS-Mutated Human Pulmonary Adenocarcinoma​
    Li, Y.; Elakad, O.; Yao, S.; von Hammerstein-Equord, A.; Hinterthaner, M. ; Danner, B. C.   & Ferrai, C. et al.​ (2022) 
    Metabolites12(7).​ DOI: https://doi.org/10.3390/metabo12070652 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​Expression and prognostic impact of DNA-PK in human lung cancer​
    Tirilomi, A.; Elakad, O.; Yao, S.; Li, Y.; Hinterthaner, M.; Danner, B. C. & Ströbel, P. et al.​ (2023) 
    Medicine102(9) art. e33143​.​ DOI: https://doi.org/10.1097/MD.0000000000033143 
    Details  DOI  PMID  PMC 
  • 2023 Journal Article | 
    ​ ​Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated KRAS in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas​
    Peng, L.; Li, Y.; Yao, S.; Baart, V. M.; Sier, C. F. M.; Ellenrieder, V. & Fuchs, F. et al.​ (2023) 
    Cancers15(5) pp. 1587​.​ DOI: https://doi.org/10.3390/cancers15051587 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page